Back to Search
JOHN IMIG, M.D.
M.D.
Gynecology Physician
NPI: 1801870530Individual
Specialties, Licenses & Credentials
Gynecology PhysicianPrimary
Obstetrics & Gynecology — Gynecology
Code: 207VG0400X
17514(CO)
Research & Publications (20)
Eicosanoids and renal damage in cardiometabolic syndrome.
PMID 18248310·Expert Opin Drug Metab Toxicol·2008
6-review
Afferent arteriolar dilation to 11, 12-EET analogs involves PP2A activity and Ca2+-activated K+ Channels.
PMID 18260004·Microcirculation·2008
7-preclinical
Cardiovascular therapeutic aspects of soluble epoxide hydrolase inhibitors.
PMID 16961727·Cardiovasc Drug Rev·2006
6-review
Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases.
PMID 16093425·Am J Physiol Renal Physiol·2005
6-review
An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension.
PMID 16157792·Hypertension·2005
7-preclinical
The Bradykinin B2 receptor is required for full expression of renal COX-2 and renin.
PMID 14612184·Peptides·2003
7-preclinical
Adaptations of the renal microcirculation to hypertension.
PMID 12152107·Microcirculation·2002
6-review
Contribution of prostaglandin EP(2) receptors to renal microvascular reactivity in mice.
PMID 12167591·Am J Physiol Renal Physiol·2002
7-preclinical
Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension.
PMID 11882632·Hypertension·2002
7-preclinical
Obesity induced renal oxidative stress contributes to renal injury in salt-sensitive hypertension.
PMID 19207724·Clin Exp Pharmacol Physiol·2009
4-observational
Soluble epoxide inhibition is protective against cerebral ischemia via vascular and neural protection.
PMID 19435785·Am J Pathol·2009
7-preclinical
Administration of a substituted adamantyl urea inhibitor of soluble epoxide hydrolase protects the kidney from damage in hypertensive Goto-Kakizaki rats.
PMID 18459944·Clin Sci (Lond)·2009
7-preclinical
Mechanisms involved in oleamide-induced vasorelaxation in rat mesenteric resistance arteries.
PMID 19326479·Eur J Pharmacol·2009
7-preclinical
Soluble epoxide hydrolase gene deletion attenuates renal injury and inflammation with DOCA-salt hypertension.
PMID 19553349·Am J Physiol Renal Physiol·2009
7-preclinical
Endothelial dysfunction and the development of renal injury in spontaneously hypertensive rats fed a high-fat diet.
PMID 18158349·Hypertension·2008
7-preclinical
Increased blood pressure in mice lacking cytochrome P450 2J5.
PMID 18716027·FASEB J·2008
7-preclinical
Identification of novel endogenous cytochrome p450 arachidonate metabolites with high affinity for cannabinoid receptors.
PMID 18606824·J Biol Chem·2008
7-preclinical
TNF-alpha inhibition reduces renal injury in DOCA-salt hypertensive rats.
PMID 17989143·Am J Physiol Regul Integr Comp Physiol·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4745 ARAPAHOE AVE, SUITE 200
BOULDER, CO 80303 - Phone
- (303) 938-4710
Quick Facts
- NPI
- 1801870530
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile